| Income Statement |
| Total Revenue | 78.73M |
|
| Revenues (USD) | 78.73M |
| Cost of Revenue | 63.70M |
| Gross Profit | 15.02M |
| Operating Expenses | 3.77M |
| Research and Development Expense | 692.00K |
| Selling, General and Administrative Expense | 1.52M |
| Operating Income | 11.25M |
| Interest Expense | 30.00K |
| Income Tax Expense | 69.00K |
| Net Income | 11.37M |
| Net Income Common Stock | 11.37M |
| Net Income Common Stock (USD) | 11.37M |
| Consolidated Income | 11.37M |
| Earnings per Basic Share | 0.25 |
| Earnings per Basic Share (USD) | 0.25 |
| Earnings per Diluted Share | 0.25 |
| Dividends per Basic Common Share | 0.01 |
| Earning Before Interest & Taxes (EBIT) | 11.47M |
| Earning Before Interest & Taxes (USD) | 11.47M |
| Weighted Average Shares | 44.03M |
| Weighted Average Shares Diluted | 44.04M |
| Balance Sheet |
| Cash and Equivalents | 34.37M |
| Cash and Equivalents (USD) | 34.37M |
| Trade and Non-Trade Receivables | 20.10M |
| Current Assets | 116.27M |
| Property, Plant & Equipment Net | 93.46M |
| Total Assets | 215.04M |
| Current Liabilities | 28.62M |
| Total Liabilities | 61.96M |
| Accumulated Retained Earnings (Deficit) | -50.36M |
| Shareholders Equity | 153.08M |
| Shareholders Equity (USD) | 153.08M |
| Assets Non-Current | 98.77M |
| Deferred Revenue | 12.64M |
| Inventory | 40.69M |
| Liabilities Non-Current | 33.34M |
| Trade and Non-Trade Payables | 23.39M |
| Tax Assets | 77.00K |
| Tax Liabilities | 1.12M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 2.77M |
| Net Cash Flow from Financing | -439.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 12.00M |
| Capital Expenditure | -7.99M |
| Payment of Dividends & Other Cash Distributions | -439.00K |
| Net Cash Flow from Investing | -6.33M |
| Net Cash Flow - Investment Acquisitions and Disposals | 1.66M |
| Net Cash Flow from Operations | 18.77M |
| Share Based Compensation | 224.00K |